Categories: Health

Mika Health partners with pharma giants for women’s oncology initiative

Spread the love

Oncology-focused digital therapeutics company Mika Health announced a partnership with pharma companies AstraZeneca and Daiichi Sankyo for an initiative dubbed “UNITE” to provide digital therapeutics to women undergoing breast cancer treatments. 

Advertisements

Mika Health’s app gives cancer patients access to psychological support to reduce disease-related anxiety, depression and stress. Patients can track side effects from medications, receive medication reminders, obtain education and nutrition advice, and coordinate appointments. 

The digital therapeutic, already certified as a medical device and released in the EU, can be personalized to an individual’s specific type of cancer.

Through the partnership, Mika Health’s offerings will be used alongside pharmaceutical therapy.

Advertisements
Advertisements

First, German-speaking patients in Switzerland can access the offering, and then the companies will expand to include Switzerland’s French- and Italian-speaking regions. 

Advertisements

“Digital therapies are becoming increasingly important in modern cancer treatment,” Adam Nosal, head of oncology at AstraZeneca Switzerland, said in a statement. “This partnership with Mika allows us to expand access to holistic cancer care and gain insights that will shape our broader efforts to improve therapeutic options for cancer patients.”

Advertisements
Advertisements

THE LARGER TREND

In June, Mika Health and the global nonprofit Cancer Support Community announced they will provide an AI-enabled oncology-focused digital therapeutic for U.S.-based cancer patients and their caregivers to access mental health and other support services free of charge. 

Earlier this year, the company announced a partnership with AI oncology firm Massive Bio to provide free access to Miko’s offerings through Massive Bio’s platform.

Mika patients would also be given the ability to participate in Massive’s AI-enabled biomarker testing and clinical trial matching offerings. 

 

The HIMSS AI in Healthcare Forum is scheduled to take place September 5-6 in Boston. Learn more and register.

 



Source link

Advertisements
Jessica Hagen

Share
Published by
Jessica Hagen

Recent Posts

The best way to enjoy and learn about the Philippines? Through food — a universal language that connects all people….

The best way to enjoy and learn about the Philippines? Through food — a universal…

6 mins ago

Bacolod mayor to address the City

Bacolod City Mayor Alfredo Abelardo Benitez will deliver his State of the City Address (Soca)…

33 mins ago

Australia politics live: Chalmers says Nationals ‘making it up as they go along’ on supermarket competition | Australian politics

Chalmers says Nationals ‘making it up as they go along’ on competition policyJim Chalmers, though,…

39 mins ago

FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’s

The Food and Drug Administration on Tuesday approved a new drug for Alzheimer’s disease, the…

49 mins ago

Charlotte, The Stingray At The Heart Of Scandal, Has Died

The slippery, chaotic, and rumor-filled saga of Charlotte the miraculously pregnant stingray has come to…

56 mins ago

Islamic Jihad, nagpaputok ng mga rocket sa Israel

Nagpaputok ng mga rocket sa Israel ang Islamic Jihad na militanteng grupo ng Palestine. Tumitindi…

1 hour ago

This website uses cookies.